entertainment -WSS

entertainment

author：fashion 2025-10-01 00:57:50 - browse：58

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Will General Catalyst be the first of many hospital takeovers?

WSS

Think you might have Covid

HPV cancer vaccine study demonstrates efficacy

A clever new way to fix Medicaid and graduate medical education

Senate panel clears PBM, hopsital reforms

MoonLake credibility takes another hit with mid

Humana cuts profit projections as Medicare Advantage costs soar

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Psychedelics group wrestles with new pharma identity

MoonLake credibility takes another hit with mid

At least 13 dead in Texas as scorching temps continue

More doctors should go into startup world

As demand for Covid shots wanes, Moderna seeks its next success

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Drug repurposing or repositioning? The language matters

Extreme heat events are a public health emergency

Virginia high school admissions case could be legal follow

The tragedy of Johnson & Johnson’s Covid vaccine

hotspot

Ambulance rides for just $100? Advisers want major billing fixes

The Sacklers, horror, and ‘The Fall of the House of Usher’

More doctors should go into startup world

AI generated plenty of interest at JPM but not a lot of trust

Francis Collins on trust in science and how Covid communications failed

EU regulator recommends expanding Mounjaro approval to obesity

entertainment

entertainment

leisure time

hotspot